DJIA 17,356.87 0.00 0.00%
NASDAQ 4,644.31 0.00 0.00%
S&P 500 2,012.89 0.00 0.00%
market minute promo

410.99 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $417.62 $6.63 (1.61%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

REGN $410.99 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $398.40
Previous Close $410.99
Daily Range $396.13 - $411.57
52-Week Range $257.69 - $437.64
Market Cap $41.8B
P/E Ratio 133.83
Dividend (Yield) $0.00 (0.0%)
Volume 674,501
Average Daily Volume 738,073
Current FY EPS $8.14

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Top Healthcare Stocks for 2014

These 10 stocks were the top large-cap performers in healthcare during 2014.

Examining Gilead Sciences' Future Pipeline

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

2015 Healthcare Sector Predictions

Water-Logged And Getting Wetter: Regeneron Pharmaceuticals (REGN)

Billionaires Are Dumping These 3 Stocks

The numbers are here, and there are three stocks billionaires are unloading now.

Can Pfizer’s Cholesterol Drug Catch Up To The Competition?

Pfizer’s bococizumab remains in last place in the PCSK9 race. Will it arrive too late to make a meaningful impact on the market?

3 Biotech Stocks to Buy in December

Three Motley Fool analysts tell investors which biotechnology stocks are on their wish list this month.

5 Biotech Stocks to Buy for 2015

These five biotech stocks may have what it takes to reward investors next year.

Cramer Says It May Finally Be Time to Buy Laggard Gilead Sciences

See More REGN News...

REGN's Top Competitors

REGN $410.99 (0.00%)
Current stock: REGN
AMGN $163.48 (0.00%)
Current stock: AMGN
GILD $102.40 (0.00%)
Current stock: GILD
BIIB $332.89 (0.00%)
Current stock: BIIB